Mallinckrodt plc Sustainability Profile
Mallinckrodt plc, a global leader in specialty pharmaceuticals, is headquartered in Ireland (IE) and operates extensively across North America and Europe. Founded in 1867, the company has a rich history marked by significant milestones in the development of innovative therapies. Specialising in pain management, autoimmune disorders, and critical care, Mallinckrodt offers a range of unique products, including specialty generics and branded medications. Their commitment to addressing unmet medical needs sets them apart in the competitive pharmaceutical landscape. With a strong market position, Mallinckrodt has achieved notable recognition for its contributions to patient care and has established itself as a trusted name in the industry. The company continues to focus on advancing healthcare solutions that improve the quality of life for patients worldwide.
DitchCarbon Score
How does Mallinckrodt plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mallinckrodt plc's score of 57 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mallinckrodt plc's reported carbon emissions
In 2024, Mallinckrodt plc reported total carbon emissions of approximately 80,934,000 kg CO2e for Scope 1, 68,201,000 kg CO2e for Scope 2, and 238,157,000 kg CO2e for Scope 3 emissions. The Scope 3 emissions breakdown includes 12,136,000 kg CO2e from capital goods, 178,886,000 kg CO2e from purchased goods and services, 24,697,000 kg CO2e from fuel and energy-related activities, and 22,438,000 kg CO2e from upstream transportation and distribution. In 2023, the company reported Scope 1 emissions of about 81,956,000 kg CO2e and Scope 2 emissions of approximately 73,947,000 kg CO2e. For 2022, the figures were 80,126,000 kg CO2e for Scope 1 and 82,349,000 kg CO2e for Scope 2. Mallinckrodt has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 emissions to near zero by 2025. This target reflects the company's commitment to sustainability and aligns with industry standards for climate action. The initiatives are part of their broader strategy to address climate change and reduce their carbon footprint significantly.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 80,126,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 82,349,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 |
How Carbon Intensive is Mallinckrodt plc's Industry?
How Carbon Intensive is Mallinckrodt plc's Location?
Mallinckrodt plc's Scope 3 Categories Breakdown
Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 61% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 75% of Scope 3 emissions.
Top Scope 3 Categories
Mallinckrodt plc's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mallinckrodt plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
